Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2014, Article ID 746979, 8 pages
http://dx.doi.org/10.1155/2014/746979
Research Article

Establishing Reliable miRNA-Cancer Association Network Based on Text-Mining Method

1Hubei Bioinformatics and Molecular Imaging Key Laboratory, Huazhong University of Science and Technology, Wuhan 430074, China
2Biomedical Engineering Department, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, Hubei 430074, China
3Department of Statistics, The University of Akron, Akron, OH 44325, USA
4Department of Family & Community Medicine, Northeast Ohio Medical University, Rootstown, OH 44272, USA
5Guizhou Provincial Key Laboratory of Computational Nano-Material Science, Guizhou Normal College, Guiyang 550018, China

Received 24 January 2014; Revised 5 March 2014; Accepted 6 March 2014; Published 10 April 2014

Academic Editor: Xiao-Qin Xia

Copyright © 2014 Lun Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Cheng, M. W. Byrom, J. Shelton, and L. P. Ford, “Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis,” Nucleic Acids Research, vol. 33, no. 4, pp. 1290–1297, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. B. D. Harfe, “MicroRNAs in vertebrate development,” Current Opinion in Genetics and Development, vol. 15, no. 4, pp. 410–415, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Wienholds, W. P. Kloosterman, E. Miska et al., “Cell biology: microRNA expression in zebrafish embryonic development,” Science, vol. 309, no. 5732, pp. 310–311, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. A. A. Shah, P. Leidinger, N. Blin, and E. Meese, “miRNA: small molecules as potential novel biomarkers in cancer,” Current Medicinal Chemistry, vol. 17, no. 36, pp. 4427–4432, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Huang and X. He, “The role of microRNAs in liver cancer progression,” British Journal of Cancer, vol. 104, no. 2, pp. 235–240, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. V. A. Krutovskikh and Z. Herceg, “Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers,” BioEssays, vol. 32, no. 10, pp. 894–904, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. C. Brase, D. Wuttig, R. Kuner, and H. Sültmann, “Serum microRNAs as non-invasive biomarkers for cancer,” Molecular Cancer, vol. 9, article 306, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. T. A. Farazi, J. I. Spitzer, P. Morozov, and T. Tuschl, “MiRNAs in human cancer,” Journal of Pathology, vol. 223, no. 2, pp. 102–115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Tazawa, S. Kagawa, and T. Fujiwara, “MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors,” Expert Opinion on Biological Therapy, vol. 11, no. 2, pp. 145–155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Lu, Q. Zhang, M. Deng et al., “An analysis of human microRNA and disease associations,” PLoS ONE, vol. 3, no. 10, Article ID e3420, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. Q. Jiang, Y. Wang, Y. Hao et al., “miR2Disease: a manually curated database for microRNA deregulation in human disease,” Nucleic Acids Research, vol. 37, no. 1, pp. D98–D104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Chen, M. X. Liu, and G. Y. Yan, “RWRMDA: predicting novel human microRNA-disease associations,” Molecular BioSystems, vol. 8, no. 10, pp. 2792–2798, 2012. View at Publisher · View at Google Scholar
  15. Q. Jiang, Y. Hao, G. Wang et al., “Prioritization of disease microRNAs through a human phenome-microRNAome network,” BMC Systems Biology, vol. 4, no. 1, article S2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Chen and Z. Zhang, “Prediction of associations between OMIM diseases and microRNAs by random walk on OMIM disease similarity network,” The Scientific World Journal, vol. 2013, Article ID 204658, 6 pages, 2013. View at Publisher · View at Google Scholar
  17. Y. A. Lussier, W. M. Stadler, and J. L. Chen, “Advantages of genomic complexity: bioinformatics opportunities in microRNA cancer signatures,” Journal of the American Medical Informatics Association, vol. 19, no. 2, pp. 156–160, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. B. J. Reinhart, F. J. Slack, M. Basson et al., “The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans,” Nature, vol. 403, no. 6772, pp. 901–906, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Ambros, B. Bartel, D. P. Bartel et al., “A uniform system for microRNA annotation,” RNA, vol. 9, no. 3, pp. 277–279, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Griffiths-Jones, H. K. Saini, S. Van Dongen, and A. J. Enright, “miRBase: tools for microRNA genomics,” Nucleic Acids Research, vol. 36, no. 1, pp. D154–D158, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. R. A. Fisher, “On the mathematical foundations of theoretical statistics,” Philosophical Transactions of the Royal Society of London Series A, vol. 222, pp. 309–368, 1922. View at Google Scholar
  22. D.-H. Le and Y.-K. Kwon, “GPEC: a cytoscape plug-in for random walk-based gene prioritization and biomedical evidence collection,” Computational Biology and Chemistry, vol. 37, pp. 17–23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. Yang, F. Ren, C. Liu et al., “DbDEMC: a database of differentially expressed miRNAs in human cancers,” BMC Genomics, vol. 11, no. 4, article S5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Wang, J. Wang, M. Lu, F. Song, and Q. Cui, “Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases,” Bioinformatics, vol. 26, no. 13, Article ID btq241, pp. 1644–1650, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. K.-H. Ling, P. J. Brautigan, C. N. Hahn et al., “Deep sequencing analysis of the developing mouse brain reveals a novel microRNA,” BMC Genomics, vol. 12, article 176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. R. L. Vinall, M. S. Kent, and D. R. W. White, “Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma,” American Journal of Veterinary Research, vol. 73, no. 10, pp. 1626–1633, 2012. View at Publisher · View at Google Scholar
  27. M. C. Speranza, V. Frattini, F. Pisati, D. Kapetis, P. Porrati et al., “NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma,” Oncotarget, vol. 3, pp. 723–734, 2012. View at Google Scholar
  28. M. L. Campanini, L. M. Colli, B. M. C. Paixao et al., “CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas,” Hormones and Cancer, vol. 1, no. 4, pp. 187–196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. H.-W. Kang, F. Wang, Q. Wei et al., “miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells,” FEBS Letters, vol. 586, no. 6, pp. 897–904, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Wang, E. S. Chan, B. C. Kwan, P. K. Li, S. K. Yip et al., “Expression of microRNAs in the urine of patients with bladder cancer,” Clinical Genitourinary Cancer, vol. 10, no. 2, pp. 106–113, 2012. View at Publisher · View at Google Scholar
  31. P. Poltronieri, P. I. D'Urso, V. Mezzolla, and O. F. D'Urso, “Potential of anti-cancer therapy based on anti-miR-155 oligonucleotides in glioma and brain tumours,” Chemical Biology and Drug Design, vol. 81, no. 1, pp. 79–84, 2013. View at Publisher · View at Google Scholar
  32. J. Rosati, F. Spallotta, S. Nanni et al., “Smad-interacting protein-1 and microRNA 200 family define a nitric oxide-dependent molecular circuitry involved in embryonic stem cell mesendoderm differentiation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 4, pp. 898–907, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Chen, Y. Sun, Y. Wei, P. Zhang, A. H. Rezaeian et al., “LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker,” Nature Medicine, vol. 18, no. 10, pp. 1511–1517, 2012. View at Publisher · View at Google Scholar
  34. O. H. Rokah, G. Granot, A. Ovcharenko, S. Modai, M. Pasmanik-Chor et al., “Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells,” PLoS ONE, vol. 7, no. 4, Article ID e35501, 2012. View at Publisher · View at Google Scholar
  35. M. Bhaskaran, D. Xi, Y. Wang, C. Huang, T. Narasaraju et al., “Identification of microRNAs changed in the neonatal lungs in response to hyperoxia exposure,” Physiological Genomics, vol. 44, no. 20, pp. 970–980, 2012. View at Publisher · View at Google Scholar
  36. M. Nugent, N. Miller, and M. J. Kerin, “Circulating miR-34a levels are reduced in colorectal cancer,” Journal of Surgical Oncology, vol. 106, no. 8, pp. 947–952, 2012. View at Publisher · View at Google Scholar
  37. R. F. Schwabe and T. C. Wang, “Targeting liver cancer: first steps toward a miRacle?” Cancer Cell, vol. 20, no. 6, pp. 698–699, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. J.-J. Huang, J. Yu, J.-Y. Li, Y.-T. Liu, and R.-Q. Zhong, “Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma,” Medical Oncology, vol. 29, no. 4, pp. 2402–2408, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Furuta, K.-I. Kozaki, S. Tanaka, S. Arii, I. Imoto, and J. Inazawa, “miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma,” Carcinogenesis, vol. 31, no. 5, pp. 766–776, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Ren, J. Gao, J. Q. Liu, X. W. Wang, J. J. Gu et al., “Differential signature of fecal microRNAs in patients with pancreatic cancer,” Molecular Medicine Reports, vol. 6, pp. 201–209, 2012. View at Google Scholar
  41. E. D. Wiklund, S. Gao, T. Hulf et al., “MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma,” PLoS ONE, vol. 6, no. 11, Article ID e27840, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Zhao, P. Xie, and H. Fan, “Genomic profiling of MicroRNAs and proteomics reveals an early molecular alteration associated with tumorigenesis induced by MC-LR in mice,” Environmental Science and Technology, vol. 46, no. 1, pp. 34–41, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Murino, M. Mammucari, D. Borrelli et al., “Role of immediate-release morphine (MIR) in the treatment of predictable pain in radiotherapy,” Journal of Pain and Palliative Care Pharmacotherapy, vol. 25, no. 2, pp. 121–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Marchini, D. Cavalieri, R. Fruscio et al., “Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections,” The Lancet Oncology, vol. 12, no. 3, pp. 273–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. L. R. Jiao, A. E. Frampton, J. Jacob et al., “Micrornas targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors,” PLoS ONE, vol. 7, no. 2, Article ID e32068, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. C. L. Li, H. Nie, M. Wang, L. P. Su, J. F. Li et al., “microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis,” Oncology Reports, vol. 27, no. 6, pp. 1960–1966, 2012. View at Publisher · View at Google Scholar
  47. C. H. Zhou, S. F. Yang, and P. Q. Li, “Human Lung Cancer cell line SPC-A1 contains cells with characteristics of cancer stem cells,” Neoplasma, vol. 59, no. 6, pp. 685–692, 2012. View at Publisher · View at Google Scholar
  48. Z. Liu, J. Zhu, H. Cao, H. Ren, and X. Fang, “miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer,” International Journal of Oncology, vol. 40, no. 5, pp. 1553–1560, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. J. A. Bishop, H. Benjamin, H. Cholakh, A. Chajut, D. P. Clark, and W. H. Westra, “Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach,” Clinical Cancer Research, vol. 16, no. 2, pp. 610–619, 2010. View at Publisher · View at Google Scholar · View at Scopus